Search Within

Alexia Elia Iasonos

  1. "Body Imaging Service"
Formats
  1. Journal Article (27)
  2. Meeting Abstract (15)
Groups
  1. Biostatistics Service (42)
  2. Body Imaging Service (42)
  3. Epidemiology and Biostatistics (42)
  4. Radiology, Department of (42)
  5. Department of Medicine (39)
  6. Solid Tumor Oncology Division (37)

More Groups

People
  1. Carol Aghajanian (27)
  2. Qin Zhou (25)
  3. Rachel Grisham (21)
  4. Vicky Makker (18)
  5. Roisin O'Cearbhaill (16)
  6. Jason Konner (15)

More People

Years
  1. 2025 (2)
  2. 2024 (5)
  3. 2023 (5)
  4. 2022 (6)
  5. 2021 (5)
  6. 2020 (7)

More Years

Publications
  1. Journal of Clinical Oncology (13)
  2. Gynecologic Oncology (10)
  3. Clinical Cancer Research (4)
  4. International Journal of Gynecological Cancer (3)
  5. Cancer (2)
  6. Blood (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (13)
  2. Elsevier Inc. (10)
  3. American Association for Cancer Research (4)
  4. Lippincott Williams & Wilkins (3)
  5. Springer (2)
  6. Wiley Blackwell (2)

More Publishers

Results (42)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of fulvestrant plus abemaciclib in hormone receptor–positive advanced or recurrent endometrial cancer
    Journal Article

    Green, A. K.; Zhou, Q.; Iasonos, A.; Zammarrelli, W. A. 3rd; Weigelt, B.; Ellenson, L. H.; Chhetri-Long, R.; Shah, P.; Loh, J.; Hom, V.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Basket study of oral progesterone antagonist onapristone extended-release in combination with anastrozole in progesterone receptor-positive recurrent adult-type granulosa cell tumor of the ovary
    Journal Article

    Finch, L.; Andres, S.; Iasonos, A.; Zhou, Q.; Girshman, J.; Chhetri-Long, R.; Green, H.; Selenica, P.; Jang, D.; O'Cearbhaill, R. E.; more...
    International Journal of Gynecological Cancer (2025)

    Fulltext@MSK | Save
  • ERBB2 mutations define a subgroup of endometrial carcinomas associated with high tumor mutational burden and the microsatellite instability-high (MSI-H) molecular subtype
    Journal Article

    Brodeur, M. N.; Selenica, P.; Ma, W.; Moufarrij, S.; Dagher, C.; Basili, T.; Abu-Rustum, N. R.; Aghajanian, C.; Zhou, Q.; Iasonos, A.; more...
    Molecular Oncology (2024)

    Fulltext@MSK | Save
  • A phase II study of fulvestrant and abemaciclib in hormone receptor positive advanced or recurrent endometrial cancer
    Meeting Abstract

    Green, A.; Zhou, Q.; Iasonos, A.; Zammarrelli, W.; Weigelt, B.; Ellenson, L. H.; Chhetri-Long, R.; Shah, P.; Hom, V.; Erinjeri, J. P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Basket study of oral progesterone antagonist onapristone extended release in progesterone receptor-positive recurrent granulosa cell, low-grade serous ovarian cancer, or endometrioid endometrial cancer
    Journal Article

    Andres, S.; Finch, L.; Iasonos, A.; Zhou, Q.; Girshman, J.; Chhetri-Long, R.; Green, H.; Jang, D.; O'Cearbhaill, R.; Kyi, C.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)
    Journal Article

    Lumish, M.; Chui, M. H.; Zhou, Q.; Iasonos, A.; Sarasohn, D.; Cohen, S.; Friedman, C.; Grisham, R.; Konner, J.; Kyi, C.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Mesonephric and mesonephric-like adenocarcinomas of gynecologic origin: A single-center experience with molecular characterization, treatment, and oncologic outcomes
    Journal Article

    Praiss, A. M.; White, C.; Iasonos, A.; Selenica, P.; Zivanovic, O.; Chi, D. S.; Abu-Rustum, N. R.; Weigelt, B.; Aghajanian, C.; Girshman, J.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • HER2 genetic intratumor heterogeneity is associated with resistance to trastuzumab and trastuzumab emtansine therapy in recurrent high-grade endometrial cancer
    Journal Article

    Shen, S.; Ma, W.; Brown, D.; Da Cruz Paula, A.; Zhou, Q.; Iaosonos, A.; Tessier-Cloutier, B.; Ross, D. S.; Troso-Sandoval, T.; Reis-Filho, J. S.; more...
    Modern Pathology (2023)

    Fulltext@MSK | Save
  • Adverse events and oncologic outcomes with combination lenvatinib and pembrolizumab for the treatment of recurrent endometrial cancer
    Journal Article

    Zammarrelli, W. A. 3rd; Ma, W.; Espino, K.; Gordhandas, S.; Yeoshoua, E.; Ehmann, S.; Zhou, Q.; Iasonos, A.; Abu-Rustum, N. R.; Aghajanian, C.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Chemotherapy response in low-grade serous ovarian carcinoma at a comprehensive cancer center: Readdressing the roles of platinum and cytotoxic therapies
    Journal Article

    Manning-Geist, B. L.; Kahn, R. M.; Nemirovsky, D.; Girshman, J.; Laibangyang, A.; Gordhandas, S.; Iasonos, A.; Chui, M. H.; Long Roche, K.; Zivanovic, O.; more...
    Cancer (2023)

    Fulltext@MSK | Save